Elevated baseline levels of hs-cTns may suggest chemotherapy-vulnerable myocardium, as evidenced by the observation that they can predict future anthracycline-induced decline in LVEF and even cardiotoxicity [16,17,30]. This evidence concerns the gene CTNS and cardiotoxicity.